New Senate Bills To Streamline Device Modifications, Expand HDEs Align With House Provisions
This article was originally published in The Gray Sheet
Two industry-supported bills introduced in the Senate parallel provisions in the 21st Century Cures bill passed by the House in July. One would allow third-party quality-system certification to supplant premarket submissions for certain modifications and another would expand the humanitarian device exemption program.
You may also be interested in...
The latest drug development news and highlights from the Pink Sheet’s US FDA Performance Tracker.
US FDA’s latest effort to provide guidance for consumers on pharmacogenomics tests underscores the challenges the agency faces in the absence of a clear regulatory framework for lab-developed tests – and with no easy mechanism to update labels for off-patent drugs.